Conventional versus binding pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial

Ann Surg. 2007 May;245(5):692-8. doi: 10.1097/01.sla.0000255588.50964.5d.

Abstract

Objective: This study compared the postoperative pancreatic anastomosis leakage rate of a new binding technique with the conventional technique of pancreaticojejunostomy after pancreaticoduodenectomy.

Summary background data: Leakage from pancreatic anastomoses remains the single most important morbidity after pancreaticoduodenectomy and contributes to prolonged hospitalization and mortality. The reported incidence after conventional pancreaticojejunostomy ranged from 10% to 29%. We previously reported a new binding pancreaticojejunostomy technique with a leakage of 0%.

Methods: We conducted a prospective randomized study on 217 patients who underwent pancreaticoduodenectomy for benign and malignant diseases of the pancreatic head and the periampullary region comparing the 2 techniques of pancreaticojejunostomy.

Results: Of the 111 patients randomized to the conventional group, pancreaticojejunostomy leakage occurred in 8 patients, while no patient in the 106 patients randomized to the binding group developed leakage (chi test, P = 0.014). The overall postoperative complications developed in 41 patients (36.9%) in the conventional group compared with 26 patients (24.5%) in the binding group (chi test, P = 0.048). Seven patients (6.3%) died in the perioperative period in the conventional group compared with 3 patients (2.8%) in the binding group (chi test, P = 0.37). The postoperative hospital stay (mean +/- SD) for the conventional group was 22.4 +/- 10.9 days, which was significantly longer than the binding group (18.4 +/- 4.7 days) (Mann-Whitney U test, P < 0.001).

Conclusions: Binding pancreaticojejunostomy after panceaticoduodenectomy significantly decreased postoperative complication and pancreaticojejunostomy leakage rates and shortened hospital stay when compared with conventional pancreaticojejunostomy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adenocarcinoma / surgery*
  • Adult
  • Common Bile Duct Neoplasms / surgery*
  • Duodenal Neoplasms / surgery*
  • Female
  • Gastrointestinal Stromal Tumors / surgery*
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / surgery*
  • Pancreaticoduodenectomy
  • Pancreaticojejunostomy / adverse effects
  • Pancreaticojejunostomy / methods*
  • Prospective Studies
  • Suture Techniques
  • Treatment Outcome